Alzheimer’s disease (AD) is a progressive neurodegenerative disease involving the alteration of gene expression at the whole genome level. Genome-wide transcriptional profiling of AD has been conducted by many groups on several relevant brain regions. However, identifying the most critical dys-regulated genes has been challenging. In this work, we addressed this issue by deriving critical genes from perturbed subnetworks. Using a recent microarray dataset on six brain regions, we applied a heaviest induced subgraph algorithm with a modular scoring function to reveal the significantly perturbed subnetwork in each brain region. These perturbed subnetworks were found to be significantly overlapped with each other. Furthermore, the hub genes fr...
Abstract Background Gene co-expression network (GCN) mining is a systematic approach to efficiently ...
Alzheimer’s disease is the most common neurological disease worldwide. Unfortunately, there are curr...
The occurrence and development of Alzheimer’s disease (AD) is a continuous clinical and pathop...
<div><p>Alzheimer’s disease (AD) is a progressive neurodegenerative disease involving the alteration...
Abstract Background Alzheimer’s disease (AD) is the most common form of dementia, characterized by p...
Abstract Background Alzheimer's disease (AD) is a progressive neurodegenerative disorder involving v...
BACKGROUND: Alzheimer's disease (AD) is the most common form of dementia, characterized by progressi...
Alzheimer’s disease (AD) is a neurodegenerative disease characterized by rapid brain cell degenerati...
Alzheimer’s Disease (AD) is the most common cause of dementia, but our understanding of its molecula...
Integration of multi-omics data with molecular interaction networks enables elucidation of the patho...
Abstract Background Transcriptional studies suggest Alzheimer's disease (AD) involves dysfunction of...
In late-onset Alzheimer's disease (AD), multiple brain regions are not affected simultaneously. Comp...
In late-onset Alzheimer's disease (AD), multiple brain regions are not affected simultaneously. Comp...
Integration of multi-omics data with molecular interaction networks enables elucidation of the patho...
Integration of multi-omics data with molecular interaction networks enables elucidation of the patho...
Abstract Background Gene co-expression network (GCN) mining is a systematic approach to efficiently ...
Alzheimer’s disease is the most common neurological disease worldwide. Unfortunately, there are curr...
The occurrence and development of Alzheimer’s disease (AD) is a continuous clinical and pathop...
<div><p>Alzheimer’s disease (AD) is a progressive neurodegenerative disease involving the alteration...
Abstract Background Alzheimer’s disease (AD) is the most common form of dementia, characterized by p...
Abstract Background Alzheimer's disease (AD) is a progressive neurodegenerative disorder involving v...
BACKGROUND: Alzheimer's disease (AD) is the most common form of dementia, characterized by progressi...
Alzheimer’s disease (AD) is a neurodegenerative disease characterized by rapid brain cell degenerati...
Alzheimer’s Disease (AD) is the most common cause of dementia, but our understanding of its molecula...
Integration of multi-omics data with molecular interaction networks enables elucidation of the patho...
Abstract Background Transcriptional studies suggest Alzheimer's disease (AD) involves dysfunction of...
In late-onset Alzheimer's disease (AD), multiple brain regions are not affected simultaneously. Comp...
In late-onset Alzheimer's disease (AD), multiple brain regions are not affected simultaneously. Comp...
Integration of multi-omics data with molecular interaction networks enables elucidation of the patho...
Integration of multi-omics data with molecular interaction networks enables elucidation of the patho...
Abstract Background Gene co-expression network (GCN) mining is a systematic approach to efficiently ...
Alzheimer’s disease is the most common neurological disease worldwide. Unfortunately, there are curr...
The occurrence and development of Alzheimer’s disease (AD) is a continuous clinical and pathop...